Genpact Limited (NYSE:G) Shares Sold by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. reduced its stake in Genpact Limited (NYSE:GFree Report) by 6.3% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 1,706,942 shares of the business services provider’s stock after selling 115,105 shares during the period. D. E. Shaw & Co. Inc.’s holdings in Genpact were worth $54,946,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of G. Vanguard Group Inc. boosted its position in shares of Genpact by 1.3% during the first quarter. Vanguard Group Inc. now owns 17,172,839 shares of the business services provider’s stock worth $565,845,000 after buying an additional 218,526 shares during the period. Fiduciary Management Inc. WI lifted its stake in Genpact by 8.5% during the 4th quarter. Fiduciary Management Inc. WI now owns 7,971,692 shares of the business services provider’s stock worth $276,697,000 after acquiring an additional 623,794 shares in the last quarter. FIL Ltd boosted its holdings in Genpact by 16.8% during the 4th quarter. FIL Ltd now owns 5,041,842 shares of the business services provider’s stock valued at $175,002,000 after acquiring an additional 725,198 shares during the period. Dimensional Fund Advisors LP grew its position in Genpact by 34.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,326,054 shares of the business services provider’s stock valued at $107,065,000 after acquiring an additional 847,249 shares in the last quarter. Finally, Capital International Investors increased its stake in Genpact by 51.8% during the first quarter. Capital International Investors now owns 3,086,957 shares of the business services provider’s stock worth $101,715,000 after purchasing an additional 1,053,236 shares during the period. Institutional investors and hedge funds own 96.03% of the company’s stock.

Genpact Stock Down 0.7 %

Shares of NYSE G opened at $38.75 on Friday. The business has a 50-day moving average of $37.25 and a two-hundred day moving average of $34.06. The company has a market capitalization of $6.97 billion, a price-to-earnings ratio of 11.07, a price-to-earnings-growth ratio of 1.63 and a beta of 1.13. Genpact Limited has a 1 year low of $29.41 and a 1 year high of $39.95. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.89 and a quick ratio of 1.89.

Genpact (NYSE:GGet Free Report) last announced its quarterly earnings results on Thursday, August 8th. The business services provider reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.64 by $0.05. Genpact had a return on equity of 22.28% and a net margin of 14.12%. The firm had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.15 billion. On average, analysts forecast that Genpact Limited will post 2.85 earnings per share for the current fiscal year.

Genpact Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 11th were given a $0.1525 dividend. The ex-dividend date was Wednesday, September 11th. This represents a $0.61 dividend on an annualized basis and a yield of 1.57%. Genpact’s dividend payout ratio (DPR) is presently 17.43%.

Analysts Set New Price Targets

Several research firms have recently commented on G. BMO Capital Markets raised their price objective on shares of Genpact from $38.00 to $42.00 and gave the company a “market perform” rating in a research note on Monday, August 12th. TD Cowen boosted their price target on shares of Genpact from $35.00 to $36.00 and gave the stock a “hold” rating in a research note on Friday, August 9th. Jefferies Financial Group upped their price objective on Genpact from $35.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 9th. JPMorgan Chase & Co. lifted their target price on Genpact from $35.00 to $43.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Finally, Needham & Company LLC increased their price target on Genpact from $40.00 to $42.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Eight analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $38.78.

Read Our Latest Stock Report on Genpact

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.